Literature DB >> 29424674

Usefulness of corset adoption after single-level lumbar discectomy: a randomized controlled trial.

Cesare Zoia1, Daniele Bongetta1,2, Cristiano Alicino3, Marcella Chimenti2, Raffaelino Pugliese1, Paolo Gaetani1.   

Abstract

OBJECTIVE In this paper, the authors sought to verify whether corset adoption could improve the short-term and midterm outcome scores of patients after single-level lumbar discectomy. METHODS A monocentric, randomized controlled trial of 54 consecutive patients who underwent single-level lumbar discectomy at the authors' institution was performed from September 2014 to August 2015. Patients were randomly assigned to use or not use a lumbar corset in the upright position. Patients with previous interventions for disc herniation or with concomitant canal or foraminal stenosis were excluded. The visual analog scale, Oswestry Disability Index, and Roland Morris Disability Questionnaire were used to compare groups at the 1- and 6-month follow-up time points. RESULTS No significant differences between the 2 groups were reported at either time point for any given outcome irrespective of the scale used. CONCLUSIONS Corset adoption does not improve the short-term and midterm outcomes of patients after single-level lumbar discectomy.

Entities:  

Keywords:  BMI = body mass index; LDH = lumbar disc herniation; VAS = visual analog scale; bracing; corset; lumbar disc herniation; lumbar discectomy

Mesh:

Year:  2018        PMID: 29424674     DOI: 10.3171/2017.8.SPINE17370

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  2 in total

Review 1.  The efficacy of postoperative bracing after spine surgery for lumbar degenerative diseases: a systematic review.

Authors:  Davide Nasi; Mauro Dobran; Giacomo Pavesi
Journal:  Eur Spine J       Date:  2019-11-01       Impact factor: 3.134

2.  An Indication-Based Concept for Stepwise Spinal Orthosis in Low Back Pain According to the Current Literature.

Authors:  Franz Landauer; Klemens Trieb
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.